Neuroectodermal Tumors, Primitive, Peripheral - 25 Studies Found
Completed |
: BEZ235 Phase II Trial in Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET) After Failure of mTOR Inhibitor Therapy. : Pancreatic Neuroendocrine Tumors (pNET) : 2012-07-06 : Drug: BEZ235 (Stage 1) The investigational study drug used in this trial was BEZ235, which was supplied |
Active, not recruiting |
: Concurrent Carboplatin and Reduced Dose Craniospinal Radiation for Medulloblastoma and Primitive Neuroectodermal Tumor (PNET) :
: 2012-02-27 : |
Completed |
: IMC-A12 in Treating Young Patients With Relapsed or Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor or Other Solid Tumor :
|
Completed |
: High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood :
|
Completed |
: Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or Rhabdomyosarcoma : Sarcoma : 1999-11-01 :
|
Completed |
: Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer :
: 1999-11-01 :
|
Completed |
: Study of Tumor Samples From Patients With Ewing Sarcoma : Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor : 2009-05-09 : Other: laboratory biomarker analysis Correlative studies |
Completed |
: Genetic Biomarkers in Saliva Samples From Patients With Ewing Sarcoma : Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor (PNET) : 2013-06-10 :
|
Recruiting |
: Efficacy and Safety of Everolimus and (STZ-5FU) Given One Upfront the Other Upon Progression in Advanced pNET : Pancreatic Neuroendocrine Tumours. : 2014-08-20 :
|
Terminated |
: Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET : Islet Cell Tumor : 2011-06-14 :
|